As a model of human PDAC, we used the human pancreatic cancer cell line COLO357PL, which carries mutant KRAS and expresses FGFR and ALK receptors as well as the ALK ligand PTN (Supplementary Figure S1) [13,15,33,34,35,40]. This evidence concerns the gene PTN and pancreatic neoplasm.